A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds

References

• Tóth A, Boczán J, Kedei N, et al. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 2005;135:162–8.
   PubMedGoogle Scholar
• Lizanecz E, Bagi Z, Pásztor ET, et al. Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. Mol Pharmacol 2006;69:1015–23.
   PubMed Web of Science ®Google Scholar
• Cavanaugh DJ, Chesler AT, Jackson AC, et al. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 2011;31:5067–77.
   PubMed Web of Science ®Google Scholar
• Duitama M, Vargas-López V, Casas Z, et al. TRP channels role in pain associated with neurodegenerative diseases. Front Neurosci 2020;14:782.
   PubMed Web of Science ®Google Scholar
• Jardín I, López JJ, Diez R, et al. TRPs in pain sensation. Front Physiol 2017;8:392.
   PubMed Web of Science ®Google Scholar
• Xie Z, Hu H. TRP channels as drug targets to relieve itch. Pharmaceuticals. 2018;11:100.
   Web of Science ®Google Scholar
• Chahl LA. TRP channels and psychiatric disorders. Adv Exp Med Biol 2011;704:987–1009.
   PubMed Web of Science ®Google Scholar
• Sun F-J, Guo W, Zheng D-H, et al. Increased expression of TRPV1 in the cortex and hippocampus from patients with mesial temporal lobe epilepsy. J Mol Neurosci 2013;49:182–93.
   PubMed Web of Science ®Google Scholar
• Gram DX, Holst JJ, Szallasi A. TRPV1: a potential therapeutic target in type 2 diabetes and comorbidities? Trends Mol Med 2017;23:1002–13.
   PubMed Web of Science ®Google Scholar
• Wang M, Ji P, Wang R, et al. TRPV1 agonist capsaicin attenuates lung ischemia-reperfusion injury in rabbits. J Surg Res 2012;173:153–60.
   PubMed Web of Science ®Google Scholar
• Ternesten-Hasséus E, Johansson K, Löwhagen O, et al. Inhalation method determines outcome of capsaicin inhalation in patients with chronic cough due to sensory hyperreactivity. Pulm Pharmacol Ther 2006;19:172–8.
   PubMed Web of Science ®Google Scholar
• Brand L, Berman E, Schwen R, et al. NE-19550: a novel, orally active anti-inflammatory analgesic. Drugs Exp Clin Res 1987;13:259–65.
   PubMedGoogle Scholar
• Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989;30:515–20.
   PubMed Web of Science ®Google Scholar
• Smart D, Gunthorpe MJ, Jerman JC, et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000;129:227–30.
   PubMed Web of Science ®Google Scholar
• Chu CJ, Huang SM, De Petrocellis L, et al. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 2003;278:13633–9.
   PubMed Web of Science ®Google Scholar
• Norman MH, Zhu J, Fotsch C, et al. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides. J Med Chem 2007;50:3497–514.
   PubMed Web of Science ®Google Scholar
• Doherty EM, Fotsch C, Bannon AW, et al. Novel vanilloid receptor-1 antagonists: 2. structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate. J Med Chem 2007;50:3515–27.
   PubMed Web of Science ®Google Scholar
• Pretze M, Pallavi P, Roscher M, et al. Radiofluorinated N-Octanoyl Dopamine ([18F]F-NOD) as a tool to study tissue distribution and elimination of NOD in vitro and in vivo. J Med Chem 2016;59:9855–65.
   PubMed Web of Science ®Google Scholar
• Pallavi P, Pretze M, Caballero J, et al. Analyses of synthetic N-acyl dopamine derivatives revealing different structural requirements for their anti-inflammatory and transient-receptor-potential-channel-of-the-vanilloid-receptor-subfamily-subtype-1 (TRPV1)-activating properties. J Med Chem 2018;61:3126–37.
   PubMed Web of Science ®Google Scholar
• Benso B, Bustos D, Zarraga MO, et al. Chalcone derivatives as non-canonical ligands of TRPV1. Int J Biochem Cell Biol 2019;112:18–23.
   PubMed Web of Science ®Google Scholar
• Ha T-H, Ryu H, Kim S-E, et al. TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides. Bioorg Med Chem 2013;21:6657–64.
   PubMed Web of Science ®Google Scholar
• Carnevale V, Rohacs T. TRPV1: a target for rational drug design. Pharmaceuticals. 2016;9:52.
   Web of Science ®Google Scholar
• Raisinghani M, Pabbidi RM, Premkumar LS. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin. J Physiol 2005;567:771–86.
   PubMed Web of Science ®Google Scholar
• Touska F, Marsakova L, Teisinger J, et al. A “cute” desensitization of TRPV1. Curr Pharm Biotechnol 2011;12:122–9.
   PubMed Web of Science ®Google Scholar
• Wrigglesworth R, Walpole CS, Bevan S, et al. Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics. J Med Chem 1996;39:4942–51.
   PubMed Web of Science ®Google Scholar
• Cho Y, Kim MS, Kim HS, et al. The SAR analysis of TRPV1 agonists with the α-methylated B-region. Bioorg Med Chem Lett 2012;22:5227–31.
   PubMed Web of Science ®Google Scholar
• Ann J, Kim HS, Thorat SA, et al. Discovery of nonpungent transient receptor potential vanilloid 1 (TRPV1) agonist as strong topical analgesic. J Med Chem 2020;63:418–24.
   PubMed Web of Science ®Google Scholar
• Li J, Nie C, Qiao Y, et al. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists. Eur J Med Chem 2019;178:433–45.
   PubMed Web of Science ®Google Scholar
• Ahn S, Kim YS, Kim MS, et al. Discovery of indane propanamides as potent and selective TRPV1 antagonists. Bioorg Med Chem Lett 2020;30:126838.
   PubMed Web of Science ®Google Scholar
• Urban L, Dray A. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro. Neurosci Lett 1991;134:9–11.
   PubMed Web of Science ®Google Scholar
• Valenzano KJ, Grant ER, Wu G, et al. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther 2003;306:377–86.
   PubMed Web of Science ®Google Scholar
• Tamayo N, Liao H, Stec MM, et al. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem 2008;51:2744–57.
   PubMed Web of Science ®Google Scholar
• Wang H-L, Katon J, Balan C, et al. Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. J Med Chem 2007;50:3528–39.
   PubMed Web of Science ®Google Scholar
• Bhondwe RS, Kang DW, Kim MS, et al. Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N’-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. Bioorg Med Chem Lett 2012;22:3656–60.
   PubMed Web of Science ®Google Scholar
• Saku O, Ishida H, Atsumi E, et al. Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem 2012;55:3436–51.
   PubMed Web of Science ®Google Scholar
• Yang F, Zheng J. Understand spiciness: mechanism of TRPV1 channel activation by capsaicin. Protein Cell 2017;8:169–77.
   PubMed Web of Science ®Google Scholar
• Fernández-Ballester G, Ferrer-Montiel A. Molecular modeling of the full-length human TRPV1 channel in closed and desensitized states. J Membr Biol 2008;223:161–72.
   PubMed Web of Science ®Google Scholar
• Moiseenkova-Bell VY, Stanciu LA, Serysheva II, et al. Structure of TRPV1 channel revealed by electron cryomicroscopy. Proc Natl Acad Sci USA 2008;105:7451–5.
   PubMed Web of Science ®Google Scholar
• Winter Z, Buhala A, Ötvös F, et al. Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel–an overview of the current mutational data. Mol Pain 2013;9:30.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee Y, Ryu H, et al. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies. J Comput Aided Mol Des 2011;25:317–27.
   PubMed Web of Science ®Google Scholar
• Kim MS, Ki Y, Ahn SY, et al. Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands. Bioorg Med Chem Lett 2014;24:382–5.
   PubMed Web of Science ®Google Scholar
• Kim N-J, Li F-N, Lee JH, et al. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities. Chem Asian J 2013;8:400–9.
   PubMed Web of Science ®Google Scholar
• Boukalova S, Marsakova L, Teisinger J, et al. Conserved residues within the putative S4-S5 region serve distinct functions among thermosensitive vanilloid transient receptor potential (TRPV) channels. J Biol Chem 2010;285:41455–62.
   PubMed Web of Science ®Google Scholar
• Liao M, Cao E, Julius D, et al. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature 2013;504:107–12.
   PubMed Web of Science ®Google Scholar
• Cao E, Liao M, Cheng Y, et al. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature 2013;504:113–8.
   PubMed Web of Science ®Google Scholar
• Gao Y, Cao E, Julius D, et al. TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action. Nature 2016;534:347–51.
   PubMed Web of Science ®Google Scholar
• Caballero J. Computational modeling to explain why 5,5-diarylpentadienamides are TRPV1 antagonists. Molecules 2021;26:1765.
   PubMed Web of Science ®Google Scholar
• Kim HS, Jin M-K, Kang S-U, et al. α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists. Bioorg Med Chem Lett 2014;24:2685–8.
   PubMed Web of Science ®Google Scholar
• Sherman W, Day T, Jacobson MP, et al. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 2006;49:534–53.
   PubMed Web of Science ®Google Scholar
• Harder E, Damm W, Maple J, et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 2016;12:281–96.
   PubMed Web of Science ®Google Scholar
• Lagoutte-Renosi J, Allemand F, Ramseyer C, et al. Molecular modeling in cardiovascular pharmacology: current state of the art and perspectives. Drug Discov Today 2021;2021:S1359-6446(21)00533-X.
   Google Scholar
• Yalcin-Ozkat G. Molecular modeling strategies of cancer multidrug resistance. Drug Resist Updat 2021;59:100789.
   PubMed Web of Science ®Google Scholar
• Alzate-Morales JH, Vergara-Jaque A, Caballero J. Computational study on the interaction of N1 substituted pyrazole derivatives with B-Raf Kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site. J Chem Inf Model 2010;50:1101–12.
   PubMed Web of Science ®Google Scholar
• Patel H, Kukol A. Integrating molecular modelling methods to advance influenza A virus drug discovery. Drug Discov Today 2021;26:503–10.
   PubMed Web of Science ®Google Scholar
• Ramírez D, Concha G, Arévalo B, et al. Discovery of Novel TASK-3 channel blockers using a pharmacophore-based virtual screening. Int J Mol Sci 2019;20:4014.
   PubMed Web of Science ®Google Scholar
• Adelusi TI, Oyedele A-QK, Boyenle ID, et al. Molecular modeling in drug discovery. Informa Med Unlocked 2022;29:100880.
   Google Scholar
• Thorat SA, Lee Y, Jung A, et al. Discovery of benzopyridone-based transient receptor potential vanilloid 1 agonists and antagonists and the structural elucidation of their activity shift. J Med Chem 2021;64:370–84.
   PubMed Web of Science ®Google Scholar
• Kang JM, Kwon SO, Ann J, et al. 2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists. Bioorg Med Chem Lett 2021;48:128266.
   PubMed Web of Science ®Google Scholar
• Å Nilsson JL, Mallet C, Shionoya K, et al. Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity. Eur J Med Chem 2021;213:113042.
   PubMed Web of Science ®Google Scholar